nodes	percent_of_prediction	percent_of_DWPC	metapath
Iobenguane—Pruritus—Vorinostat—hematologic cancer	0.0053	0.0053	CcSEcCtD
Iobenguane—Flushing—Nilotinib—hematologic cancer	0.00505	0.00505	CcSEcCtD
Iobenguane—Flushing—Imatinib—hematologic cancer	0.00502	0.00502	CcSEcCtD
Iobenguane—Dizziness—Vorinostat—hematologic cancer	0.00496	0.00496	CcSEcCtD
Iobenguane—Contusion—Prednisone—hematologic cancer	0.00475	0.00475	CcSEcCtD
Iobenguane—Hypersensitivity—Mechlorethamine—hematologic cancer	0.00474	0.00474	CcSEcCtD
Iobenguane—Headache—Vorinostat—hematologic cancer	0.00469	0.00469	CcSEcCtD
Iobenguane—Pruritus—Mechlorethamine—hematologic cancer	0.00455	0.00455	CcSEcCtD
Iobenguane—Flushing—Melphalan—hematologic cancer	0.0045	0.0045	CcSEcCtD
Iobenguane—Flushing—Lenalidomide—hematologic cancer	0.00437	0.00437	CcSEcCtD
Iobenguane—Rash—Mechlorethamine—hematologic cancer	0.00406	0.00406	CcSEcCtD
Iobenguane—Dermatitis—Mechlorethamine—hematologic cancer	0.00405	0.00405	CcSEcCtD
Iobenguane—Flushing—Bortezomib—hematologic cancer	0.00402	0.00402	CcSEcCtD
Iobenguane—Flushing—Bleomycin—hematologic cancer	0.00399	0.00399	CcSEcCtD
Iobenguane—Flushing—Vinorelbine—hematologic cancer	0.00393	0.00393	CcSEcCtD
Iobenguane—Hypersensitivity—Methoxsalen—hematologic cancer	0.00391	0.00391	CcSEcCtD
Iobenguane—Hypersensitivity—Mercaptopurine—hematologic cancer	0.0038	0.0038	CcSEcCtD
Iobenguane—Pruritus—Methoxsalen—hematologic cancer	0.00375	0.00375	CcSEcCtD
Iobenguane—Hypersensitivity—Clofarabine—hematologic cancer	0.00374	0.00374	CcSEcCtD
Iobenguane—Hypersensitivity—Daunorubicin—hematologic cancer	0.00374	0.00374	CcSEcCtD
Iobenguane—Hypersensitivity—Pentostatin—hematologic cancer	0.00373	0.00373	CcSEcCtD
Iobenguane—Pruritus—Clofarabine—hematologic cancer	0.00359	0.00359	CcSEcCtD
Iobenguane—Pruritus—Daunorubicin—hematologic cancer	0.00359	0.00359	CcSEcCtD
Iobenguane—Hypersensitivity—Idarubicin—hematologic cancer	0.00359	0.00359	CcSEcCtD
Iobenguane—Dizziness—Nelarabine—hematologic cancer	0.00359	0.00359	CcSEcCtD
Iobenguane—Pruritus—Anagrelide—hematologic cancer	0.00358	0.00358	CcSEcCtD
Iobenguane—Pruritus—Pentostatin—hematologic cancer	0.00358	0.00358	CcSEcCtD
Iobenguane—Dizziness—Methoxsalen—hematologic cancer	0.00351	0.00351	CcSEcCtD
Iobenguane—Hypersensitivity—Teniposide—hematologic cancer	0.0035	0.0035	CcSEcCtD
Iobenguane—Flushing—Carmustine—hematologic cancer	0.00349	0.00349	CcSEcCtD
Iobenguane—Flushing—Alitretinoin—hematologic cancer	0.00345	0.00345	CcSEcCtD
Iobenguane—Flushing—Ifosfamide—hematologic cancer	0.00341	0.00341	CcSEcCtD
Iobenguane—Headache—Nelarabine—hematologic cancer	0.0034	0.0034	CcSEcCtD
Iobenguane—Dizziness—Clofarabine—hematologic cancer	0.00336	0.00336	CcSEcCtD
Iobenguane—Dizziness—Daunorubicin—hematologic cancer	0.00336	0.00336	CcSEcCtD
Iobenguane—Pruritus—Teniposide—hematologic cancer	0.00336	0.00336	CcSEcCtD
Iobenguane—Dizziness—Pentostatin—hematologic cancer	0.00334	0.00334	CcSEcCtD
Iobenguane—Dizziness—Anagrelide—hematologic cancer	0.00334	0.00334	CcSEcCtD
Iobenguane—Rash—Methoxsalen—hematologic cancer	0.00334	0.00334	CcSEcCtD
Iobenguane—Dermatitis—Methoxsalen—hematologic cancer	0.00334	0.00334	CcSEcCtD
Iobenguane—Headache—Methoxsalen—hematologic cancer	0.00332	0.00332	CcSEcCtD
Iobenguane—Rash—Mercaptopurine—hematologic cancer	0.00325	0.00325	CcSEcCtD
Iobenguane—Dermatitis—Mercaptopurine—hematologic cancer	0.00324	0.00324	CcSEcCtD
Iobenguane—Flushing—Irinotecan—hematologic cancer	0.00324	0.00324	CcSEcCtD
Iobenguane—Hypersensitivity—Busulfan—hematologic cancer	0.00324	0.00324	CcSEcCtD
Iobenguane—Rash—Clofarabine—hematologic cancer	0.0032	0.0032	CcSEcCtD
Iobenguane—Rash—Daunorubicin—hematologic cancer	0.0032	0.0032	CcSEcCtD
Iobenguane—Dermatitis—Clofarabine—hematologic cancer	0.0032	0.0032	CcSEcCtD
Iobenguane—Dermatitis—Daunorubicin—hematologic cancer	0.0032	0.0032	CcSEcCtD
Iobenguane—Rash—Anagrelide—hematologic cancer	0.00319	0.00319	CcSEcCtD
Iobenguane—Rash—Pentostatin—hematologic cancer	0.00319	0.00319	CcSEcCtD
Iobenguane—Dermatitis—Pentostatin—hematologic cancer	0.00319	0.00319	CcSEcCtD
Iobenguane—Dermatitis—Anagrelide—hematologic cancer	0.00319	0.00319	CcSEcCtD
Iobenguane—Headache—Clofarabine—hematologic cancer	0.00318	0.00318	CcSEcCtD
Iobenguane—Headache—Daunorubicin—hematologic cancer	0.00318	0.00318	CcSEcCtD
Iobenguane—Headache—Pentostatin—hematologic cancer	0.00317	0.00317	CcSEcCtD
Iobenguane—Headache—Anagrelide—hematologic cancer	0.00317	0.00317	CcSEcCtD
Iobenguane—Hypersensitivity—Procarbazine—hematologic cancer	0.00314	0.00314	CcSEcCtD
Iobenguane—Pruritus—Busulfan—hematologic cancer	0.00311	0.00311	CcSEcCtD
Iobenguane—Hypersensitivity—Dasatinib—hematologic cancer	0.00308	0.00308	CcSEcCtD
Iobenguane—Hypersensitivity—Bexarotene—hematologic cancer	0.00308	0.00308	CcSEcCtD
Iobenguane—Rash—Idarubicin—hematologic cancer	0.00308	0.00308	CcSEcCtD
Iobenguane—Dermatitis—Idarubicin—hematologic cancer	0.00307	0.00307	CcSEcCtD
Iobenguane—Hypersensitivity—Fludarabine—hematologic cancer	0.00307	0.00307	CcSEcCtD
Iobenguane—Headache—Idarubicin—hematologic cancer	0.00306	0.00306	CcSEcCtD
Iobenguane—Pruritus—Procarbazine—hematologic cancer	0.00302	0.00302	CcSEcCtD
Iobenguane—Rash—Teniposide—hematologic cancer	0.00299	0.00299	CcSEcCtD
Iobenguane—Dermatitis—Teniposide—hematologic cancer	0.00299	0.00299	CcSEcCtD
Iobenguane—Headache—Teniposide—hematologic cancer	0.00297	0.00297	CcSEcCtD
Iobenguane—Pruritus—Dasatinib—hematologic cancer	0.00296	0.00296	CcSEcCtD
Iobenguane—Pruritus—Bexarotene—hematologic cancer	0.00296	0.00296	CcSEcCtD
Iobenguane—Pruritus—Fludarabine—hematologic cancer	0.00295	0.00295	CcSEcCtD
Iobenguane—Flushing—Cisplatin—hematologic cancer	0.00294	0.00294	CcSEcCtD
Iobenguane—Hypersensitivity—Chlorambucil—hematologic cancer	0.00291	0.00291	CcSEcCtD
Iobenguane—Dizziness—Busulfan—hematologic cancer	0.00291	0.00291	CcSEcCtD
Iobenguane—Hypersensitivity—Nilotinib—hematologic cancer	0.00285	0.00285	CcSEcCtD
Iobenguane—Hypersensitivity—Imatinib—hematologic cancer	0.00283	0.00283	CcSEcCtD
Iobenguane—Dizziness—Procarbazine—hematologic cancer	0.00282	0.00282	CcSEcCtD
Iobenguane—Pruritus—Chlorambucil—hematologic cancer	0.00279	0.00279	CcSEcCtD
Iobenguane—Hypersensitivity—Cladribine—hematologic cancer	0.00278	0.00278	CcSEcCtD
Iobenguane—Rash—Busulfan—hematologic cancer	0.00277	0.00277	CcSEcCtD
Iobenguane—Dermatitis—Busulfan—hematologic cancer	0.00277	0.00277	CcSEcCtD
Iobenguane—Dizziness—Bexarotene—hematologic cancer	0.00277	0.00277	CcSEcCtD
Iobenguane—Dizziness—Dasatinib—hematologic cancer	0.00277	0.00277	CcSEcCtD
Iobenguane—Headache—Busulfan—hematologic cancer	0.00275	0.00275	CcSEcCtD
Iobenguane—Pruritus—Nilotinib—hematologic cancer	0.00273	0.00273	CcSEcCtD
Iobenguane—Pruritus—Imatinib—hematologic cancer	0.00272	0.00272	CcSEcCtD
Iobenguane—Flushing—Etoposide—hematologic cancer	0.0027	0.0027	CcSEcCtD
Iobenguane—Rash—Procarbazine—hematologic cancer	0.00269	0.00269	CcSEcCtD
Iobenguane—Dermatitis—Procarbazine—hematologic cancer	0.00269	0.00269	CcSEcCtD
Iobenguane—Headache—Procarbazine—hematologic cancer	0.00267	0.00267	CcSEcCtD
Iobenguane—Pruritus—Cladribine—hematologic cancer	0.00267	0.00267	CcSEcCtD
Iobenguane—Hypersensitivity—Vinblastine—hematologic cancer	0.00267	0.00267	CcSEcCtD
Iobenguane—Rash—Bexarotene—hematologic cancer	0.00264	0.00264	CcSEcCtD
Iobenguane—Rash—Dasatinib—hematologic cancer	0.00264	0.00264	CcSEcCtD
Iobenguane—Dermatitis—Bexarotene—hematologic cancer	0.00263	0.00263	CcSEcCtD
Iobenguane—Dermatitis—Dasatinib—hematologic cancer	0.00263	0.00263	CcSEcCtD
Iobenguane—Rash—Fludarabine—hematologic cancer	0.00263	0.00263	CcSEcCtD
Iobenguane—Dermatitis—Fludarabine—hematologic cancer	0.00263	0.00263	CcSEcCtD
Iobenguane—Headache—Bexarotene—hematologic cancer	0.00262	0.00262	CcSEcCtD
Iobenguane—Headache—Dasatinib—hematologic cancer	0.00262	0.00262	CcSEcCtD
Iobenguane—Headache—Fludarabine—hematologic cancer	0.00261	0.00261	CcSEcCtD
Iobenguane—Dizziness—Nilotinib—hematologic cancer	0.00255	0.00255	CcSEcCtD
Iobenguane—Dizziness—Imatinib—hematologic cancer	0.00254	0.00254	CcSEcCtD
Iobenguane—Hypersensitivity—Melphalan—hematologic cancer	0.00254	0.00254	CcSEcCtD
Iobenguane—Dizziness—Cladribine—hematologic cancer	0.0025	0.0025	CcSEcCtD
Iobenguane—Hypersensitivity—Lenalidomide—hematologic cancer	0.00247	0.00247	CcSEcCtD
Iobenguane—Pruritus—Melphalan—hematologic cancer	0.00244	0.00244	CcSEcCtD
Iobenguane—Rash—Nilotinib—hematologic cancer	0.00244	0.00244	CcSEcCtD
Iobenguane—Dermatitis—Nilotinib—hematologic cancer	0.00243	0.00243	CcSEcCtD
Iobenguane—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00243	0.00243	CcSEcCtD
Iobenguane—Rash—Imatinib—hematologic cancer	0.00242	0.00242	CcSEcCtD
Iobenguane—Headache—Nilotinib—hematologic cancer	0.00242	0.00242	CcSEcCtD
Iobenguane—Dermatitis—Imatinib—hematologic cancer	0.00242	0.00242	CcSEcCtD
Iobenguane—Headache—Imatinib—hematologic cancer	0.00241	0.00241	CcSEcCtD
Iobenguane—Dizziness—Vinblastine—hematologic cancer	0.00239	0.00239	CcSEcCtD
Iobenguane—Rash—Cladribine—hematologic cancer	0.00238	0.00238	CcSEcCtD
Iobenguane—Dermatitis—Cladribine—hematologic cancer	0.00238	0.00238	CcSEcCtD
Iobenguane—Pruritus—Lenalidomide—hematologic cancer	0.00237	0.00237	CcSEcCtD
Iobenguane—Headache—Cladribine—hematologic cancer	0.00236	0.00236	CcSEcCtD
Iobenguane—Hypersensitivity—Bortezomib—hematologic cancer	0.00227	0.00227	CcSEcCtD
Iobenguane—Headache—Vinblastine—hematologic cancer	0.00227	0.00227	CcSEcCtD
Iobenguane—Hypersensitivity—Bleomycin—hematologic cancer	0.00225	0.00225	CcSEcCtD
Iobenguane—Hypersensitivity—Vinorelbine—hematologic cancer	0.00222	0.00222	CcSEcCtD
Iobenguane—Dizziness—Lenalidomide—hematologic cancer	0.00221	0.00221	CcSEcCtD
Iobenguane—Dizziness—Hydroxyurea—hematologic cancer	0.00218	0.00218	CcSEcCtD
Iobenguane—Pruritus—Bortezomib—hematologic cancer	0.00218	0.00218	CcSEcCtD
Iobenguane—Rash—Melphalan—hematologic cancer	0.00217	0.00217	CcSEcCtD
Iobenguane—Dermatitis—Melphalan—hematologic cancer	0.00217	0.00217	CcSEcCtD
Iobenguane—Pruritus—Bleomycin—hematologic cancer	0.00216	0.00216	CcSEcCtD
Iobenguane—Pruritus—Vinorelbine—hematologic cancer	0.00213	0.00213	CcSEcCtD
Iobenguane—Hypersensitivity—Thiotepa—hematologic cancer	0.00212	0.00212	CcSEcCtD
Iobenguane—Rash—Lenalidomide—hematologic cancer	0.00211	0.00211	CcSEcCtD
Iobenguane—Dermatitis—Lenalidomide—hematologic cancer	0.00211	0.00211	CcSEcCtD
Iobenguane—Headache—Lenalidomide—hematologic cancer	0.0021	0.0021	CcSEcCtD
Iobenguane—Rash—Hydroxyurea—hematologic cancer	0.00208	0.00208	CcSEcCtD
Iobenguane—Dermatitis—Hydroxyurea—hematologic cancer	0.00208	0.00208	CcSEcCtD
Iobenguane—Headache—Hydroxyurea—hematologic cancer	0.00207	0.00207	CcSEcCtD
Iobenguane—Hypersensitivity—Thalidomide—hematologic cancer	0.00205	0.00205	CcSEcCtD
Iobenguane—Dizziness—Bortezomib—hematologic cancer	0.00204	0.00204	CcSEcCtD
Iobenguane—Pruritus—Thiotepa—hematologic cancer	0.00203	0.00203	CcSEcCtD
Iobenguane—Dizziness—Vinorelbine—hematologic cancer	0.00199	0.00199	CcSEcCtD
Iobenguane—Hypersensitivity—Carmustine—hematologic cancer	0.00197	0.00197	CcSEcCtD
Iobenguane—Pruritus—Thalidomide—hematologic cancer	0.00197	0.00197	CcSEcCtD
Iobenguane—Hypersensitivity—Alitretinoin—hematologic cancer	0.00195	0.00195	CcSEcCtD
Iobenguane—Rash—Bortezomib—hematologic cancer	0.00194	0.00194	CcSEcCtD
Iobenguane—Dermatitis—Bortezomib—hematologic cancer	0.00194	0.00194	CcSEcCtD
Iobenguane—Flushing—Prednisone—hematologic cancer	0.00193	0.00193	CcSEcCtD
Iobenguane—Headache—Bortezomib—hematologic cancer	0.00193	0.00193	CcSEcCtD
Iobenguane—Rash—Bleomycin—hematologic cancer	0.00193	0.00193	CcSEcCtD
Iobenguane—Dermatitis—Bleomycin—hematologic cancer	0.00193	0.00193	CcSEcCtD
Iobenguane—Hypersensitivity—Ifosfamide—hematologic cancer	0.00193	0.00193	CcSEcCtD
Iobenguane—Dizziness—Thiotepa—hematologic cancer	0.0019	0.0019	CcSEcCtD
Iobenguane—Rash—Vinorelbine—hematologic cancer	0.0019	0.0019	CcSEcCtD
Iobenguane—Dermatitis—Vinorelbine—hematologic cancer	0.0019	0.0019	CcSEcCtD
Iobenguane—Headache—Vinorelbine—hematologic cancer	0.00188	0.00188	CcSEcCtD
Iobenguane—Hypersensitivity—Vincristine—hematologic cancer	0.00188	0.00188	CcSEcCtD
Iobenguane—Pruritus—Alitretinoin—hematologic cancer	0.00187	0.00187	CcSEcCtD
Iobenguane—Pruritus—Ifosfamide—hematologic cancer	0.00185	0.00185	CcSEcCtD
Iobenguane—Dizziness—Thalidomide—hematologic cancer	0.00184	0.00184	CcSEcCtD
Iobenguane—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00183	0.00183	CcSEcCtD
Iobenguane—Hypersensitivity—Irinotecan—hematologic cancer	0.00183	0.00183	CcSEcCtD
Iobenguane—Rash—Thiotepa—hematologic cancer	0.00181	0.00181	CcSEcCtD
Iobenguane—Dermatitis—Thiotepa—hematologic cancer	0.00181	0.00181	CcSEcCtD
Iobenguane—Headache—Thiotepa—hematologic cancer	0.0018	0.0018	CcSEcCtD
Iobenguane—Dizziness—Carmustine—hematologic cancer	0.00176	0.00176	CcSEcCtD
Iobenguane—Rash—Thalidomide—hematologic cancer	0.00175	0.00175	CcSEcCtD
Iobenguane—Dermatitis—Thalidomide—hematologic cancer	0.00175	0.00175	CcSEcCtD
Iobenguane—Dizziness—Alitretinoin—hematologic cancer	0.00175	0.00175	CcSEcCtD
Iobenguane—Headache—Thalidomide—hematologic cancer	0.00174	0.00174	CcSEcCtD
Iobenguane—Dizziness—Ifosfamide—hematologic cancer	0.00173	0.00173	CcSEcCtD
Iobenguane—Pruritus—Gemcitabine—hematologic cancer	0.00171	0.00171	CcSEcCtD
Iobenguane—Dizziness—Vincristine—hematologic cancer	0.00168	0.00168	CcSEcCtD
Iobenguane—Rash—Carmustine—hematologic cancer	0.00168	0.00168	CcSEcCtD
Iobenguane—Dermatitis—Carmustine—hematologic cancer	0.00168	0.00168	CcSEcCtD
Iobenguane—Headache—Carmustine—hematologic cancer	0.00167	0.00167	CcSEcCtD
Iobenguane—Rash—Alitretinoin—hematologic cancer	0.00167	0.00167	CcSEcCtD
Iobenguane—Dermatitis—Alitretinoin—hematologic cancer	0.00167	0.00167	CcSEcCtD
Iobenguane—Hypersensitivity—Cisplatin—hematologic cancer	0.00166	0.00166	CcSEcCtD
Iobenguane—Headache—Alitretinoin—hematologic cancer	0.00166	0.00166	CcSEcCtD
Iobenguane—Rash—Ifosfamide—hematologic cancer	0.00165	0.00165	CcSEcCtD
Iobenguane—Dermatitis—Ifosfamide—hematologic cancer	0.00165	0.00165	CcSEcCtD
Iobenguane—Dizziness—Irinotecan—hematologic cancer	0.00164	0.00164	CcSEcCtD
Iobenguane—Rash—Vincristine—hematologic cancer	0.00161	0.00161	CcSEcCtD
Iobenguane—Dermatitis—Vincristine—hematologic cancer	0.0016	0.0016	CcSEcCtD
Iobenguane—Headache—Vincristine—hematologic cancer	0.0016	0.0016	CcSEcCtD
Iobenguane—Rash—Irinotecan—hematologic cancer	0.00156	0.00156	CcSEcCtD
Iobenguane—Rash—Mitoxantrone—hematologic cancer	0.00156	0.00156	CcSEcCtD
Iobenguane—Dermatitis—Mitoxantrone—hematologic cancer	0.00156	0.00156	CcSEcCtD
Iobenguane—Dermatitis—Irinotecan—hematologic cancer	0.00156	0.00156	CcSEcCtD
Iobenguane—Headache—Mitoxantrone—hematologic cancer	0.00155	0.00155	CcSEcCtD
Iobenguane—Headache—Irinotecan—hematologic cancer	0.00155	0.00155	CcSEcCtD
Iobenguane—Rash—Gemcitabine—hematologic cancer	0.00152	0.00152	CcSEcCtD
Iobenguane—Dermatitis—Gemcitabine—hematologic cancer	0.00152	0.00152	CcSEcCtD
Iobenguane—Hypersensitivity—Etoposide—hematologic cancer	0.00152	0.00152	CcSEcCtD
Iobenguane—Headache—Gemcitabine—hematologic cancer	0.00151	0.00151	CcSEcCtD
Iobenguane—Flushing—Epirubicin—hematologic cancer	0.00151	0.00151	CcSEcCtD
Iobenguane—Hypersensitivity—Prednisolone—hematologic cancer	0.0015	0.0015	CcSEcCtD
Iobenguane—Pruritus—Etoposide—hematologic cancer	0.00146	0.00146	CcSEcCtD
Iobenguane—Rash—Cisplatin—hematologic cancer	0.00142	0.00142	CcSEcCtD
Iobenguane—Dermatitis—Cisplatin—hematologic cancer	0.00142	0.00142	CcSEcCtD
Iobenguane—Flushing—Doxorubicin—hematologic cancer	0.0014	0.0014	CcSEcCtD
Iobenguane—Hypersensitivity—Triamcinolone—hematologic cancer	0.00138	0.00138	CcSEcCtD
Iobenguane—Dizziness—Etoposide—hematologic cancer	0.00136	0.00136	CcSEcCtD
Iobenguane—Dizziness—Prednisolone—hematologic cancer	0.00135	0.00135	CcSEcCtD
Iobenguane—Pruritus—Triamcinolone—hematologic cancer	0.00132	0.00132	CcSEcCtD
Iobenguane—Rash—Etoposide—hematologic cancer	0.0013	0.0013	CcSEcCtD
Iobenguane—Dermatitis—Etoposide—hematologic cancer	0.0013	0.0013	CcSEcCtD
Iobenguane—Headache—Etoposide—hematologic cancer	0.00129	0.00129	CcSEcCtD
Iobenguane—Rash—Prednisolone—hematologic cancer	0.00128	0.00128	CcSEcCtD
Iobenguane—Dermatitis—Prednisolone—hematologic cancer	0.00128	0.00128	CcSEcCtD
Iobenguane—Headache—Prednisolone—hematologic cancer	0.00128	0.00128	CcSEcCtD
Iobenguane—Dizziness—Triamcinolone—hematologic cancer	0.00124	0.00124	CcSEcCtD
Iobenguane—Pruritus—Betamethasone—hematologic cancer	0.0012	0.0012	CcSEcCtD
Iobenguane—Pruritus—Dexamethasone—hematologic cancer	0.0012	0.0012	CcSEcCtD
Iobenguane—Rash—Triamcinolone—hematologic cancer	0.00118	0.00118	CcSEcCtD
Iobenguane—Dermatitis—Triamcinolone—hematologic cancer	0.00118	0.00118	CcSEcCtD
Iobenguane—Headache—Triamcinolone—hematologic cancer	0.00117	0.00117	CcSEcCtD
Iobenguane—Dizziness—Dexamethasone—hematologic cancer	0.00112	0.00112	CcSEcCtD
Iobenguane—Dizziness—Betamethasone—hematologic cancer	0.00112	0.00112	CcSEcCtD
Iobenguane—Hypersensitivity—Prednisone—hematologic cancer	0.00109	0.00109	CcSEcCtD
Iobenguane—Rash—Dexamethasone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Iobenguane—Rash—Betamethasone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Iobenguane—Dermatitis—Dexamethasone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Iobenguane—Dermatitis—Betamethasone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Iobenguane—Headache—Dexamethasone—hematologic cancer	0.00106	0.00106	CcSEcCtD
Iobenguane—Headache—Betamethasone—hematologic cancer	0.00106	0.00106	CcSEcCtD
Iobenguane—Pruritus—Prednisone—hematologic cancer	0.00105	0.00105	CcSEcCtD
Iobenguane—Dizziness—Prednisone—hematologic cancer	0.000978	0.000978	CcSEcCtD
Iobenguane—Rash—Prednisone—hematologic cancer	0.000933	0.000933	CcSEcCtD
Iobenguane—Dermatitis—Prednisone—hematologic cancer	0.000932	0.000932	CcSEcCtD
Iobenguane—Headache—Prednisone—hematologic cancer	0.000927	0.000927	CcSEcCtD
Iobenguane—Hypersensitivity—Methotrexate—hematologic cancer	0.000911	0.000911	CcSEcCtD
Iobenguane—Pruritus—Methotrexate—hematologic cancer	0.000875	0.000875	CcSEcCtD
Iobenguane—Hypersensitivity—Epirubicin—hematologic cancer	0.000852	0.000852	CcSEcCtD
Iobenguane—Pruritus—Epirubicin—hematologic cancer	0.000818	0.000818	CcSEcCtD
Iobenguane—Dizziness—Methotrexate—hematologic cancer	0.000817	0.000817	CcSEcCtD
Iobenguane—Hypersensitivity—Doxorubicin—hematologic cancer	0.000789	0.000789	CcSEcCtD
Iobenguane—Rash—Methotrexate—hematologic cancer	0.000779	0.000779	CcSEcCtD
Iobenguane—Dermatitis—Methotrexate—hematologic cancer	0.000779	0.000779	CcSEcCtD
Iobenguane—Headache—Methotrexate—hematologic cancer	0.000774	0.000774	CcSEcCtD
Iobenguane—Dizziness—Epirubicin—hematologic cancer	0.000765	0.000765	CcSEcCtD
Iobenguane—Pruritus—Doxorubicin—hematologic cancer	0.000757	0.000757	CcSEcCtD
Iobenguane—Rash—Epirubicin—hematologic cancer	0.000729	0.000729	CcSEcCtD
Iobenguane—Dermatitis—Epirubicin—hematologic cancer	0.000729	0.000729	CcSEcCtD
Iobenguane—Headache—Epirubicin—hematologic cancer	0.000725	0.000725	CcSEcCtD
Iobenguane—Dizziness—Doxorubicin—hematologic cancer	0.000708	0.000708	CcSEcCtD
Iobenguane—Rash—Doxorubicin—hematologic cancer	0.000675	0.000675	CcSEcCtD
Iobenguane—Dermatitis—Doxorubicin—hematologic cancer	0.000674	0.000674	CcSEcCtD
Iobenguane—Headache—Doxorubicin—hematologic cancer	0.000671	0.000671	CcSEcCtD
